Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Larkin

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|August 8, 2013
Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapyN S Vasudev, V Goh, J K Juttla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimusJames M G Larkin, Rosalie A Fisher, Lisa M Pickering, et al.
The British Journal of Dermatology|February 16, 2007
Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanomaL A Fearfield, J M G Larkin, A Rowe, et al.
The Lancet. Psychiatry|July 27, 2020
Venezuelan migrants in Colombia: COVID-19 and mental healthZelde Espinel, Roberto Chaskel, Ryan C Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2013
Prognostic and predictive markers in metastatic renal cell carcinomaMuhammad A Khattak, Farrah Bakr, Marcin Krzystanek, et al.
British Journal of Cancer|December 6, 2006
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanomaJ M G Larkin, S A Hughes, D A Beirne, et al.
British Journal of Cancer|September 16, 2010
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinomaJ M G Larkin, T R Ferguson, L M Pickering, et al.
Ecology Letters|June 14, 2018
Relative importance of competition and plant-soil feedback, their synergy, context dependency and implications for coexistenceYlva Lekberg, James D Bever, Rebecca A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidenceDesiree F Kolomainen, James M G Larkin, Mohammad Badran, et al.
The Lancet. Oncology|August 8, 2016
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trialBrian I Rini, Tanya B Dorff, Paul Elson, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|August 8, 2013
Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapyN S Vasudev, V Goh, J K Juttla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimusJames M G Larkin, Rosalie A Fisher, Lisa M Pickering, et al.
The British Journal of Dermatology|February 16, 2007
Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanomaL A Fearfield, J M G Larkin, A Rowe, et al.
The Lancet. Psychiatry|July 27, 2020
Venezuelan migrants in Colombia: COVID-19 and mental healthZelde Espinel, Roberto Chaskel, Ryan C Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2013
Prognostic and predictive markers in metastatic renal cell carcinomaMuhammad A Khattak, Farrah Bakr, Marcin Krzystanek, et al.
British Journal of Cancer|December 6, 2006
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanomaJ M G Larkin, S A Hughes, D A Beirne, et al.
British Journal of Cancer|September 16, 2010
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinomaJ M G Larkin, T R Ferguson, L M Pickering, et al.
Ecology Letters|June 14, 2018
Relative importance of competition and plant-soil feedback, their synergy, context dependency and implications for coexistenceYlva Lekberg, James D Bever, Rebecca A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidenceDesiree F Kolomainen, James M G Larkin, Mohammad Badran, et al.
The Lancet. Oncology|August 8, 2016
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trialBrian I Rini, Tanya B Dorff, Paul Elson, et al.
Pageof 13